Abbott Laboratories (NYSE:ABT) Issues Earnings Results, Hits Estimates

Abbott Laboratories (NYSE:ABT) Issues Earnings Results, Hits Estimates

Abbott Laboratories (NYSE:ABT - Get Free Report) posted its quarterly earnings results on Wednesday. The healthcare product maker reported $1.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.42. The business had revenue of $13.01 billion during the quarter, compared to the consensus estimate of $12.99 billion. Abbott Laboratories had a net margin of 11.65% and a return on equity of 17.69%.

Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance

/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2026. Third-quarter sales increased 14.5 percent on...

Abbott Q3 Revenue Reaches $13.01 Billion, Exceeds Estimates

Adjusted diluted earnings were $1.42 per share, topping estimates by $0.01. Abbott reaffirmed its 2026 earnings outlook.

Abbott Labs posts Q3 sales of $13B, up 14.5%

Abbott Laboratories announced on Wednesday that its net sales in the third quarter of fiscal 2026 came in at $13.01 billion, growing 14.5% year-over-year, while comparable sales grew 7%.Diluted earnin...